Husain Sattar to Breast Neoplasms
This is a "connection" page, showing publications Husain Sattar has written about Breast Neoplasms.
Connection Strength
0.677
-
Lobular neoplasia of the breast: an update. Arch Pathol Lab Med. 2009 Jul; 133(7):1116-20.
Score: 0.133
-
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 11 01; 157(11):1034-1041.
Score: 0.084
-
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials. Ann Oncol. 2022 08; 33(8):814-823.
Score: 0.081
-
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663.
Score: 0.078
-
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362.
Score: 0.072
-
Angular restriction fluorescence optical projection tomography to localize micrometastases in lymph nodes. J Biomed Opt. 2019 11; 24(11):1-4.
Score: 0.068
-
WNT10B/ß-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Mol Med. 2013 Feb; 5(2):264-79.
Score: 0.042
-
Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802.
Score: 0.042
-
Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
Score: 0.040
-
Computerized three-class classification of MRI-based prognostic markers for breast cancer. Phys Med Biol. 2011 Sep 21; 56(18):5995-6008.
Score: 0.038